Page last updated: 2024-08-24

ziprasidone and Parkinson Disease, Secondary

ziprasidone has been researched along with Parkinson Disease, Secondary in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (80.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Al-Jadiri, A; Azzo, S; Carbon, M; Correll, CU; Kane, JM; Kapoor, S; Saito, E; Sarkaria, T; Sheridan, E	1
Buhl, D; Lamkin, S	1
Bilal, L; Gasper, JJ; Ndlela, JC; Tsai, C	1
Schindehütte, J; Trenkwalder, C	1
de Oliveira Lança, G; Hara, C; Kascher, GG; Magalhães Scoralick, F; Ramos, MG; Rocha, FL; Santos, MA	1

Trials

1 trial(s) available for ziprasidone and Parkinson Disease, Secondary

Article	Year
An exploratory open-label trial of ziprasidone for the treatment of behavioral and psychological symptoms of dementia. Dementia and geriatric cognitive disorders, 2006, Volume: 22, Issue:5-6 Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Dementia; Disorders of Excessive Somnolence; Drug Administration Schedule; Female; Gastrointestinal Diseases; Humans; Male; Mental Disorders; Middle Aged; Parkinson Disease, Secondary; Piperazines; Thiazoles	2006

Article

Year

An exploratory open-label trial of ziprasidone for the treatment of behavioral and psychological symptoms of dementia.

Dementia and geriatric cognitive disorders, 2006, Volume: 22, Issue:5-6

Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Dementia; Disorders of Excessive Somnolence; Drug Administration Schedule; Female; Gastrointestinal Diseases; Humans; Male; Mental Disorders; Middle Aged; Parkinson Disease, Secondary; Piperazines; Thiazoles

2006

Other Studies

4 other study(ies) available for ziprasidone and Parkinson Disease, Secondary

Article	Year
Neuromotor Adverse Effects in 342 Youth During 12 Weeks of Naturalistic Treatment With 5 Second-Generation Antipsychotics. Journal of the American Academy of Child and Adolescent Psychiatry, 2015, Volume: 54, Issue:9 Topics: Adolescent; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Male; Mental Disorders; Multivariate Analysis; New York; Olanzapine; Parkinson Disease, Secondary; Piperazines; Prospective Studies; Quetiapine Fumarate; Regression Analysis; Risperidone; Thiazoles	2015
Extrapyramidal side effects: could you identify them in the emergency department? Journal of emergency nursing, 2009, Volume: 35, Issue:1 Topics: Acute Disease; Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Dopamine Antagonists; Dyskinesia, Drug-Induced; Dystonia; Emergency Nursing; Emergency Treatment; Female; Humans; Infant; Male; Muscle Rigidity; Nursing Assessment; Parkinson Disease, Secondary; Piperazines; Risk Factors; Risperidone; Syndrome; Thiazoles	2009
Parkinsonism with intramuscular ziprasidone. The American journal of psychiatry, 2005, Volume: 162, Issue:12 Topics: Antipsychotic Agents; Dose-Response Relationship, Drug; Humans; Injections, Intramuscular; Male; Middle Aged; Parkinson Disease, Secondary; Piperazines; Schizophrenia, Paranoid; Thiazoles; Violence	2005
Treatment of drug-induced psychosis in Parkinson's disease with ziprasidone can induce severe dose-dependent off-periods and pathological laughing. Clinical neurology and neurosurgery, 2007, Volume: 109, Issue:2 Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Clozapine; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Laughter; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Parkinson Disease, Secondary; Piperazines; Psychoses, Substance-Induced; Quetiapine Fumarate; Thiazoles	2007